Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data
Hauer, L; Sellner, J
DRUG DES DEV THER. 2022; 16: 3915-3927.
Übersichtsarbeiten

A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.
Kuemmel, S; Campone, M; Loirat, D; Lopez, RL; Beck, JT; De Laurentiis, M; Im, SA; Kim, SB; Kwong, A; Steger, GG; Adelantado, EZ; Duhoux, FP; Greil, R; Kuter, I; Lu, YS; Tibau, A; Özgüroğlu, M; Scholz, CW; Singer, CF; Vega, E; Wimberger, P; Zamagni, C; Couillebault, XM; Fan, L; Guerreiro, N; Mataraza, J; Sand-Dejmek, J; Chan, A;
Clin Cancer Res. 2022; 28(1): 106-115.
Originalarbeiten (Zeitschrift)

Atogepant for the Prevention of Episodic Migraine in Adults: A Systematic Review and Meta-Analysis of Efficacy and Safety.
Lattanzi, S; Trinka, E; Altamura, C; Del Giovane, C; Silvestrini, M; Brigo, F; Vernieri, F
NEUROL THER. 2022; 11(3): 1235-1252.
Übersichtsarbeiten

A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery.
Lorenzl, S; Gottwald, F; Nistler, A; Brehm, L; Grötsch, R; Haber, G; Bremm, C; Weck, C; Trummer, C; Brand, W;
Med Cannabis Cannabinoids. 2022; 5(1):-19
Originalarbeiten (Zeitschrift)

Diagnosis and treatment of arterial hypertension 2021.
Ott, C; Schmieder, RE;
Kidney Int. 2022; 101(1): 3-46.
Übersichtsarbeiten

A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14.
Rentsch, CA; Thalmann, GN; Lucca, I; Kwiatkowski, M; Wirth, GJ; Strebel, RT; Engeler, D; Pedrazzini, A; Hüttenbrink, C; Schultze-Seemann, W; Torpai, R; Bubendorf, L; Wicki, A; Roth, B; Bosshard, P; Püschel, H; Boll, DT; Hefermehl, L; Roghmann, F; Gierth, M; Ribi, K; Schäfer, S; Hayoz, S;
Eur Urol Oncol. 2022; 5(2): 195-202.
Originalarbeiten (Zeitschrift)

[Wound therapy with cold atmospheric plasma in severe recessive dystrophic epidermolysis bullosa : A pilot study].
Thiem, A; Has, C; Diem, A; Klausegger, A; Hamm, H; Emmert, S;
Hautarzt. 2022; 73(5): 384-390.
Fallberichte

A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder Cancer.
Yanagisawa, T; Quhal, F; Kawada, T; Mostafaei, H; Motlagh, RS; Laukhtina, E; Rajwa, P; Deimling, MV; Bianchi, A; Pallauf, M; Majdoub, M; Pradere, B; Moschini, M; Karakiewicz, PI; Teoh, JY; Miki, J; Kimura, T; Shariat, SF;
Eur Urol Focus. 2022;
Übersichtsarbeiten

Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa.
Kiritsi, D; Dieter, K; Niebergall-Roth, E; Fluhr, S; Daniele, C; Esterlechner, J; Sadeghi, S; Ballikaya, S; Erdinger, L; Schauer, F; Gewert, S; Laimer, M; Bauer, JW; Hovnanian, A; Zambruno, G; El Hachem, M; Bourrat, E; Papanikolaou, M; Petrof, G; Kitzmüller, S; Ebens, CL; Frank, MH; Frank, NY; Ganss, C; Martinez, AE; McGrath, JA; Tolar, J; Kluth, MA;
JCI Insight. 2021; 6(22):
Originalarbeiten (Zeitschrift)

Pharmacokinetics and safety of capmatinib with food in patients with MET-dysregulated advanced solid tumors.
Moreno, V; Greil, R; Yachnin, J; Majem, M; Wermke, M; Arkenau, HT; Basque, JR; Nidamarthy, PK; Kapoor, S; Cui, XM; Giovannini, M
CLIN THER. 2021; 43(6): 1092-1111.
Originalarbeiten (Zeitschrift)

Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany.
Strzelczyk, A; Pringsheim, M; Mayer, T; Polster, T; Klotz, KA; Muhle, H; Alber, M; Trollmann, R; Spors, H; Kluger, G; Kurlemann, G; Schubert-Bast, S
Epilepsia. 2021; 62(10):2518-2527
Originalarbeiten (Zeitschrift)

PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice
Villanueva, V; D'Souza, W; Goji, H; Kim, DW; Liguori, C; McMurray, R; Najm, I; Santamarina, E; Steinhoff, BJ; Vlasov, P; Wu, T; Trinka, E
J NEUROL. 2021;
Originalarbeiten (Zeitschrift)

Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients" Perspectives.
Willems, LM; Rosenow, F; Schubert-Bast, S; Kurlemann, G; Zollner, JP; Bast, T; Bertsche, A; Bettendorf, U; Ebrahimi-Fakhari, D; Grau, J; Hahn, A; Hartmann, H; Hertzberg, C; Hornemann, F; Immisch, I; Jacobs, J; Klein, KM; Klotz, KA; Kluger, G; Knake, S; Knuf, M; Marquard, K; Mayer, T; Meyer, S; Muhle, H; Muller-Schluter, K; von Podewils, F; Ruf, S; Sauter, M; Schafer, H; Schlump, JU; Syrbe, S; Thiels, C; Trollmann, R; Wiemer-Kruel, A; Wilken, B; Zukunft, B; Strzelczyk, A
CNS DRUGS. 2021; 35(10): 1107-1122.
Originalarbeiten (Zeitschrift)

Single-use IgE-selective immunoadsorber column for the treatment of severe atopic dermatitis.
Meyersburg, D; Laimer, M; Kugler, A; Mühlthaler, E; Lindlbauer, N; Hitzl, W; Rohde, E; Bauer, JW; Grabmer, C;
J Clin Apher. 2020; 35(1): 50-58.
Originalarbeiten (Zeitschrift)

Translational perspectives to treat Epidermolysis bullosa-Where do we stand?
Prodinger, C; Bauer, JW; Laimer, M;
Exp Dermatol. 2020; 29(11):1112-1122
Originalarbeiten (Zeitschrift)

Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria.
Rendl, G; Sipos, B; Becherer, A; Sorko, S; Trummer, C; Raderer, M; Hitzl, W; Ardelt, M; Gallowitsch, HJ; Pirich, C;
Int J Endocrinol. 2020; 2020: 8834148
Originalarbeiten (Zeitschrift)

Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.
Sävendahl, L; Battelino, T; Brod, M; Højby Rasmussen, M; Horikawa, R; Juul, RV; Saenger, P;
J Clin Endocrinol Metab. 2020; 105(4):
Originalarbeiten (Zeitschrift)

A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity.
Weghuber, D; Forslund, A; Ahlström, H; Alderborn, A; Bergström, K; Brunner, S; Cadamuro, J; Ciba, I; Dahlbom, M; Heu, V; Hofmann, J; Kristinsson, H; Kullberg, J; Ladinger, A; Lagler, FB; Lidström, M; Manell, H; Meirik, M; Mörwald, K; Roomp, K; Schneider, R; Vilén, H; Widhalm, K; Zsoldos, F; Bergsten, P;
Pediatr Obes. 2020; 15(7): e12624
Originalarbeiten (Zeitschrift)

Antiepileptic drug monotherapy for epilepsy in the elderly: A systematic review and network meta-analysis.
Lattanzi, S; Trinka, E; Del Giovane, C; Nardone, R; Silvestrini, M; Brigo, F;
Epilepsia. 2019; 60(11):-2254.
Originalarbeiten (Zeitschrift)

Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis.
Lattanzi, S; Zaccara, G; Giovannelli, F; Grillo, E; Nardone, R; Silvestrini, M; Trinka, E; Brigo, F;
Acta Neurol Scand. 2019; 139(1): 33-41.
Übersichtsarbeiten

Perampanel: Does it have broad-spectrum potential?
Potschka, H; Trinka, E;
Epilepsia. 2019; 60 Suppl 1:22-36
Übersichtsarbeiten

Perampanel in the treatment of status epilepticus: A systematic review of the literature.
Brigo, F; Lattanzi, S; Rohracher, A; Russo, E; Meletti, S; Grillo, E; Trinka, E
EPILEPSY BEHAV. 2018; 86: 179-186.
Übersichtsarbeiten

Randomized controlled trials of antiepileptic drugs for the treatment of post-stroke seizures: A systematic review with network meta-analysis.
Brigo, F; Lattanzi, S; Zelano, J; Bragazzi, NL; Belcastro, V; Nardone, R; Trinka, E;
Seizure. 2018; 61: 57-62.
Übersichtsarbeiten

Decolonization potential of 0.02% polyhexanide irrigation solution in urethral catheters under practice-like in vitro conditions.
Brill, FHH; Gabriel, H; Brill, H; Klock, JH; Steinmann, J; Arndt, A;
BMC Urol. 2018; 18(1): 49
Originalarbeiten (Zeitschrift)

Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice - results from the ElderTac study.
Brueckl, WM; Achenbach, HJ; Ficker, JH; Schuette, W;
BMC Cancer. 2018; 18(1): 333
Originalarbeiten (Zeitschrift)

A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.
Burgstaller, S; Stauder, R; Kuehr, T; Lang, A; Machherndl-Spandl, S; Mayrbaeurl, B; Noesslinger, T; Petzer, A; Valent, P; Greil, R; Thaler, J;
Leuk Lymphoma. 2018; 59(5):1121-1126
Originalarbeiten (Zeitschrift)

A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc
Greil, R; Greil-Ressler, S; Weiss, L; Schönlieb, C; Magnes, T; Radl, B; Bolger, GT; Vcelar, B; Sordillo, PP;
Cancer Chemother Pharmacol. 2018; 82(4): 695-706.
Originalarbeiten (Zeitschrift)

Development of encorafenib for BRAF-mutated advanced melanoma.
Koelblinger, P; Thuerigen, O; Dummer, R;
Curr Opin Oncol. 2018; 30(2): 125-133.
Originalarbeiten (Zeitschrift)

Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials.
Krauss, G; Biton, V; Harvey, JH; Elger, C; Trinka, E; Soares da Silva, P; Gama, H; Cheng, H; Grinnell, T; Blum, D;
Epilepsy Res. 2018; 139:1-8
Originalarbeiten (Zeitschrift)

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Fuchs, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Bartsch, R; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R;
BMC Cancer. 2018; 18(1): 1074
Originalarbeiten (Zeitschrift)

Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
Biton, V; Rogin, JB; Krauss, G; Abou-Khalil, B; Rocha, JF; Moreira, J; Gama, H; Trinka, E; Elger, CE; Cheng, HL; Grinnell, T; Blum, D
Epilepsy Behav. 2017; 72:127-134
Originalarbeiten (Zeitschrift)

Advanced non-small cell lung cancer (NSCLC) with activating EGFR mutations: first-line treatment with afatinib and other EGFR TKIs.
Brückl, W; Tufman, A; Huber, RM;
Expert Rev Anticancer Ther. 2017; 17(2): 143-155.
Originalarbeiten (Zeitschrift)

Re: Auch mit DOAK bleibt es kompliziert
Engels, T; Hoppenrath, HG; Gosch, M; Heppner, HJ;
MMW Fortschr Med. 2017; 159(6): 26
Author reply

The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.
Fountoulakis, KN; Yatham, L; Grunze, H; Vieta, E; Young, A; Blier, P; Kasper, S; Moeller, HJ
Int J Neuropsychopharmacol. 2017; 20(2):121-179
Übersichtsarbeiten

Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study.
Schmid, E; Kuchukhidze, G; Kirschner, M; Leitinger, M; Höfler, J; Rohracher, A; Kalss, G; Wendling, AS; Steinhoff, BJ; Trinka, E;
Acta Neurol Scand. 2017; 135(4): 449-453.
Originalarbeiten (Zeitschrift)

Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.
Shorvon, SD; Trinka, E; Steinhoff, BJ; Holtkamp, M; Villanueva, V; Peltola, J; Ben-Menachem, E;
J Neurol. 2017; 264(3): 42-431.
Übersichtsarbeiten

Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials.
Brigo, F; Bragazzi, NL; Bacigaluppi, S; Nardone, R; Trinka, E;
Epilepsy Behav. 2016; 64(Pt A): 29-36.
Übersichtsarbeiten

Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
Brigo, F; Bragazzi, NL; Nardone, R; Trinka, E;
Seizure. 2016; 42:29-37
Übersichtsarbeiten

The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Levin, J; Maass, S; Schuberth, M; Respondek, G; Paul, F; Mansmann, U; Oertel, WH; Lorenzl, S; Krismer, F; Seppi, K; Poewe, W; Wenning, G; Giese, A; Botzel, K; Hoglinger, G
J NEURAL TRANSM. 2016; 123(4): 439-445.
Originalarbeiten (Zeitschrift)

PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy.
Nuebling, G; Hensler, M; Paul, S; Zwergal, A; Crispin, A; Lorenzl, S;
J Neurol. 2016; 263(8): 1565-1574.
Originalarbeiten (Zeitschrift)

Perampanel for the treatment of primary generalized tonic-clonic seizures in idiopathic generalized epilepsy.
Rohracher, A; Brigo, F; Höfler, J; Kalss, G; Neuray, C; Dobesberger, J; Kuchukhidze, G; Leitinger, M; Trinka, E;
Expert Opin Pharmacother. 2016; 17(10):1403-1411
Originalarbeiten (Zeitschrift)

Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data
Rohracher, A; Kalss, G; Leitinger, M; Granbichler, C; Deak, I; Dobesberger, J; Kuchukhidze, G; Thomschewski, A; Hofler, J; Trinka, E
THER ADV NEUROL DISO. 2016; 9(6): 445-453.
Originalarbeiten (Zeitschrift)

Pharmacologic treatment of status epilepticus.
Trinka, E; Höfler, J; Leitinger, M; Rohracher, A; Kalss, G; Brigo, F;
Expert Opin Pharmacother. 2016; 17(4):51-34
Originalarbeiten (Zeitschrift)

Perampanel for focal epilepsy: insights from early clinical experience.
Trinka, E; Steinhoff, BJ; Nikanorova, M; Brodie, MJ;
Acta Neurol Scand. 2016; 133(3): 160-172.
Übersichtsarbeiten

Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain.
Ueberall, MA; Lorenzl, S; Lux, EA; Voltz, R; Perelman, M;
J Pain Res. 2016; 9: 571-585.
Originalarbeiten (Zeitschrift)

Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies: first experiences.
Biro, A; Stephani, U; Tarallo, T; Bast, T; Schlachter, K; Fleger, M; Kurlemann, G; Fiedler, B; Leiz, S; Nikanorova, M; Wolff, M; Muller, A; Selch, C; Staudt, M; Kluger, G
NEUROPEDIATRICS. 2015; 46(2): 110-115.
Originalarbeiten (Zeitschrift)

Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.
Brinton, EA; Kher, U; Shah, S; Cannon, CP; Davidson, M; Gotto, AM; Ashraf, TB; McCrary Sisk, C; Dansky, H; Mitchel, Y; Barter, P;
J Clin Lipidol. 2015; 9(1): 65-71.
Originalarbeiten (Zeitschrift)

Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I.
Grunze, H; Kotlik, E; Costa, R; Nunes, T; Falcão, A; Almeida, L; Soares-da-Silva, P;
J Affect Disord. 2015; 174:70-82
Originalarbeiten (Zeitschrift)

Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial.
Mohr, P; Hauschild, A; Trefzer, U; Enk, A; Tilgen, W; Loquai, C; Gogas, H; Haalck, T; Koller, J; Dummer, R; Gutzmer, R; Brockmeyer, N; Holzle, E; Sunderkotter, C; Mauch, C; Stein, A; Schneider, LA; Podda, M; Goppner, D; Schadendorf, D; Weichenthal, M
J Clin Oncol. 2015; 33(34):4077-4084
Originalarbeiten (Zeitschrift)

Safety and tolerability of anticonvulsant medication in bipolar disorder.
Pichler, EM; Hattwich, G; Grunze, H; Muehlbacher, M;
Expert Opin Drug Saf. 2015; 14(11):1703-1724
Originalarbeiten (Zeitschrift)

Nothing like Christmas--suicides during Christmas and other holidays in Austria.
Plöderl, M; Fartacek, C; Kunrath, S; Pichler, EM; Fartacek, R; Datz, C; Niederseer, D;
Eur J Public Health. 2015; 25(3): 410-413.
Originalarbeiten (Zeitschrift)

Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
Tomic, V; Tomic, J; Klaic, DZ; Kasum, M; Kuna, K;
Eur J Obstet Gynecol Reprod Biol. 2015; 186: 49-53.
Originalarbeiten (Zeitschrift)

Collagenase clostridium histolyticum in patients with Dupuytren"s contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes.
Warwick, D; Arner, M; Pajardi, G; Reichert, B; Szabo, Z; Masmejean, EH; Fores, J; Chapman, DS; Gerber, RA; Huard, F; Seghouani, A; Szczypa, PP;
J Hand Surg Eur Vol. 2015; 40(2):124-132
Originalarbeiten (Zeitschrift)

A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy.
Werhahn, KJ; Trinka, E; Dobesberger, J; Unterberger, I; Baum, P; Deckert-Schmitz, M; Kniess, T; Schmitz, B; Bernedo, V; Ruckes, C; Ehrlich, A; Kramer, G
EPILEPSIA. 2015; 56(3): 450-459.
Originalarbeiten (Zeitschrift)

A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia.
Awan, FT; Hillmen, P; Hellmann, A; Robak, T; Hughes, SG; Trone, D; Shannon, M; Flinn, IW; Byrd, JC;
Br J Haematol. 2014; 167(4): 466-477.
Originalarbeiten (Zeitschrift)

Analysis of the safety and pharmacodynamics of human fibrinogen concentrate in animals.
Beyerle, A; Nolte, MW; Solomon, C; Herzog, E; Dickneite, G
TOXICOL APPL PHARM. 2014; 280(1): 70-77.
Originalarbeiten (Zeitschrift)

Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial.
Eisterer, W; De Vries, A; Öfner, D; Rabl, H; Koplmüller, R; Greil, R; Tschmelitsch, J; Schmid, R; Kapp, K; Lukas, P; Sedlmayer, F; Höfler, G; Gnant, M; Thaler, J;
Anticancer Res. 2014; 34(11):676-673
Originalarbeiten (Zeitschrift)

A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).
Hutterer, M; Nowosielski, M; Haybaeck, J; Embacher, S; Stockhammer, F; Gotwald, T; Holzner, B; Capper, D; Preusser, M; Marosi, C; Oberndorfer, S; Moik, M; Buchroithner, J; Seiz, M; Tuettenberg, J; Herrlinger, U; Wick, A; Vajkoczy, P; Stockhammer, G;
Neuro Oncol. 2014; 16(1):9-102
Originalarbeiten (Zeitschrift)

Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
Kwan, P; Trinka, E; Van Paesschen, W; Rektor, I; Johnson, ME; Lu, S;
Epilepsia. 2014; 55(1):38-46
Originalarbeiten (Zeitschrift)

When to start aripiprazole therapy in patients with bipolar mania.
Sayyaparaju, KK; Grunze, H; Fountoulakis, KN;
Neuropsychiatr Dis Treat. 2014; 10:459-470
Übersichtsarbeiten

Intravenous sildenafil i.v. as rescue treatment for refractory pulmonary hypertension in extremely preterm infants.
Steiner, M; Salzer, U; Baumgartner, S; Waldhoer, T; Klebermass-Schrehof, K; Wald, M; Langgartner, M; Berger, A;
Klin Padiatr. 2014; 226(4):211-215
Originalarbeiten (Zeitschrift)

Efficacy and safety of intravenous valproate for status epilepticus: a systematic review.
Trinka, E; Höfler, J; Zerbs, A; Brigo, F;
CNS Drugs. 2014; 28(7):623-639
Originalarbeiten (Zeitschrift)

The established status epilepticus trial 2013.
Bleck, T; Cock, H; Chamberlain, J; Cloyd, J; Connor, J; Elm, J; Fountain, N; Jones, E; Lowenstein, D; Shinnar, S; Silbergleit, R; Treiman, D; Trinka, E; Kapur, J;
Epilepsia. 2013; 54 Suppl 6: 89-92.
Originalarbeiten (Zeitschrift)

Development of new treatment approaches for epilepsy: Unmet needs and opportunities.
French, JA; White, HS; Klitgaard, H; Holmes, GL; Privitera, MD; Cole, AJ; Quay, E; Wiebe, S; Schmidt, D; Porter, RJ; Arzimanoglou, A; Trinka, E; Perucca, E;
Epilepsia. 2013; 54 Suppl 4: 3-12.
Originalarbeiten (Zeitschrift)

Safety and tolerability of zonisamide in elderly patients with epilepsy.
Trinka, E; Giorgi, L; Patten, A; Segieth, J;
Acta Neurol Scand. 2013; 128(6):422-428
Originalarbeiten (Zeitschrift)

TOLERABILITY AND SAFETY OF ZONISAMIDE IN ELDERLY PATIENTS WITH PARTIAL EPILEPSY: RESULTS OF A POOLED ANALYSIS
Trinka, E; Segieth, J; Giorgi, L
J NEUROL NEUROSUR PS. 2013; 84(11):
Abstracts (Zeitschrift)

Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial.
Aschner, P; Chan, J; Owens, DR; Picard, S; Wang, E; Dain, MP; Pilorget, V; Echtay, A; Fonseca, V;
Lancet. 2012; 379(9833): 2262-2269.
Originalarbeiten (Zeitschrift)

Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study.
Thaler, J; Karthaus, M; Mineur, L; Greil, R; Letocha, H; Hofheinz, R; Fernebro, E; Gamelin, E; Baños, A; Köhne, CH;
BMC Cancer. 2012; 12: 438
Originalarbeiten (Zeitschrift)

Ideal characteristics of an antiepileptic drug: how do these impact treatment decisions for individual patients?
Trinka, E
ACTA NEUROL SCAND. 2012; 126(194): 10-18.
Übersichtsarbeiten

First long-term experience with the orphan drug rufinamide in children with myoclonic-astatic epilepsy (Doose syndrome).
von Stülpnagel, C; Coppola, G; Striano, P; Müller, A; Staudt, M; Kluger, G;
EUR J PAEDIATR NEURO. 2012; 16(5): 459-463.
Originalarbeiten (Zeitschrift)

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.
Fischer von Weikersthal, L; Schalhorn, A; Stauch, M; Quietzsch, D; Maubach, PA; Lambertz, H; Oruzio, D; Schlag, R; Weigang-Köhler, K; Vehling-Kaiser, U; Schulze, M; Truckenbrodt, J; Goebeler, M; Mittermüller, J; Bosse, D; Szukics, B; Grundeis, M; Zwingers, T; Giessen, C; Heinemann, V;
Eur J Cancer. 2011; 47(2): 206-214.
Originalarbeiten (Zeitschrift)

Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma.
Gökbuget, N; Hartog, CM; Bassan, R; Derigs, HG; Dombret, H; Greil, R; Hernández-Rivas, JM; Huguet, F; Intermesoli, T; Jourdan, E; Junghanss, C; Leimer, L; Moreno, MJ; Reichle, A; Ribera, J; Schmid, M; Serve, H; Stelljes, M; Stuhlmann, R; Hoelzer, D;
Haematologica. 2011; 96(2): 238-244.
Originalarbeiten (Zeitschrift)

Intravenous lacosamide in status epilepticus and seizure clusters.
Höfler, J; Unterberger, I; Dobesberger, J; Kuchukhidze, G; Walser, G; Trinka, E;
Epilepsia. 2011; 52(10): e148-e152.
Originalarbeiten (Zeitschrift)

Intravenous lacosamide for treatment of status epilepticus.
Kellinghaus, C; Berning, S; Immisch, I; Larch, J; Rosenow, F; Rossetti, AO; Tilz, C; Trinka, E;
Acta Neurol Scand. 2011; 123(2): 137-141.
Originalarbeiten (Zeitschrift)

[Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate].
Steinhoff, BJ; Trinka, E; Wendling, AS;
Nervenarzt. 2011; 82(6): 764-767.
Originalarbeiten (Zeitschrift)

Oral micronized progesterone combined with vaginal progesterone gel for luteal support.
Tomic, V; Tomic, J; Klaic, DZ;
Gynecol Endocrinol. 2011; 27(12): 1010-1013.
Originalarbeiten (Zeitschrift)

What is the evidence to use new intravenous AEDs in status epilepticus?
Trinka, E
EPILEPSIA. 2011; 52: 35-38.
Originalarbeiten (Zeitschrift)

Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen.
Brucker, C; Hedon, B; The, HS; Höschen, K; Binder, N; Christoph, A;
Contraception. 2010; 81(6): 501-509.
Originalarbeiten (Zeitschrift)

Flexible dosing of adjunctive zonisamide in the treatment of adult partial-onset seizures: a non-comparative, open-label study (ZEUS).
Dupont, S; Striano, S; Trinka, E; Springub, J; Giallonardo, AT; Smith, P; Ellis, S; Yeates, A; Baker, G;
Acta Neurol Scand. 2010; 121(3):141-148
Originalarbeiten (Zeitschrift)

[Acute and long-term treatment for bipolar depression].
Grunze, H; Dargel, S;
Nervenarzt. 2010; 81(5):539-548
Originalarbeiten (Zeitschrift)

New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
Lagler, FB; Gersting, SW; Zsifkovits, C; Steinbacher, A; Eichinger, A; Danecka, MK; Staudigl, M; Fingerhut, R; Glossmann, H; Muntau, AC;
Biochem Pharmacol. 2010; 80(10): 1563-1571.
Originalarbeiten (Zeitschrift)

Nonresected non-small-cell lung cancer in Stages I through IIIB: accelerated, twice-daily, high-dose radiotherapy--a prospective Phase I/II trial with long-term follow-up.
Wurstbauer, K; Deutschmann, H; Kopp, P; Kranzinger, M; Merz, F; Nairz, O; Studnicka, M; Sedlmayer, F;
INT J RADIAT ONCOL. 2010; 77(5): 134-151.
Originalarbeiten (Zeitschrift)

Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib.
Cannon, CP; Dansky, HM; Davidson, M; Gotto, AM; Brinton, EA; Gould, AL; Stepanavage, M; Liu, SX; Shah, S; Rubino, J; Gibbons, P; Hermanowski-Vosatka, A; Binkowitz, B; Mitchel, Y; Barter, P;
Am Heart J. 2009; 158(4):-519.e3.
Originalarbeiten (Zeitschrift)

New treatment options in status epilepticus: a critical review on intravenous levetiracetam.
Trinka, E; Dobesberger, J;
Ther Adv Neurol Disord. 2009; 2(2):79-91
Originalarbeiten (Zeitschrift)

A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
Bowden, C; Göğüş, A; Grunze, H; Häggström, L; Rybakowski, J; Vieta, E;
Int Clin Psychopharmacol. 2008; 23(5):254-262
Originalarbeiten (Zeitschrift)

Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing: results of clinical experience in Germany.
Brucker, C; Karck, U; Merkle, E;
Eur J Contracept Reprod Health Care. 2008; 13(1): 31-38.
Originalarbeiten (Zeitschrift)

Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
Jakesz, R; Greil, R; Gnant, M; Schmid, M; Kwasny, W; Kubista, E; Mlineritsch, B; Tausch, C; Stierer, M; Hofbauer, F; Renner, K; Dadak, C; Rücklinger, E; Samonigg, H;
J Natl Cancer Inst. 2007; 99(24):1845-1853
Originalarbeiten (Zeitschrift)

Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.
Simunic, V; Tomic, V; Tomic, J; Nizic, D;
Fertil Steril. 2007; 87(1): 83-87.
Originalarbeiten (Zeitschrift)

Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
von Stuelpnagel, C; Holthausen, H; Kluger, G;
Eur J Paediatr Neurol. 2007; 11(6): 341-345.
Originalarbeiten (Zeitschrift)

Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients.
Mühlbacher, M; Konstantinidis, A; Kasper, S; Eichberger, G; Hinterhuber, H; Hofmann, P; Nimmerrichter, A; Schubert, H; Egger, C; Nickel, M; Stuppaeck, C;
Neuropsychobiology. 2006; 53(2):83-87
Originalarbeiten (Zeitschrift)

First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055.
Raus, K; Brucker, C; Gorkow, C; Wuttke, W;
Menopause. 2006; 13(4): 678-691.
Originalarbeiten (Zeitschrift)

Treatment of a large coronary saphenous bypass graft aneurysm by implantation of covered stents.
Zahn, R; Jessl, J; Achenbach, S; Ropers, D; Schwab, J; Daniel, W
Clin Res Cardiol. 2006; 95(6):313-315
Originalarbeiten (Zeitschrift)

Zotepine loading in acute and severely manic patients: a pilot study.
Amann, B; Sterr, A; Mergl, R; Dittmann, S; Seemüller, F; Dobmeier, M; Orth, M; Schaefer, M; Grunze, H;
Bipolar Disord. 2005; 7(5):471-476
Originalarbeiten (Zeitschrift)

Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany
Opp, J; Tuxhorn, I; May, T; Kluger, G; Wiemer-Kruel, A; Kurlemann, G; Gross-Selbeck, G; Rating, D; Brandl, U; Bettendorf, U; Hartel, C; Korn-Merker, E
SEIZURE-EUR J EPILEP. 2005; 14(7): 476-484.
Originalarbeiten (Zeitschrift)

The safety and tolerability of atypical antipsychotics in bipolar disorder.
Seemüller, F; Forsthoff, A; Dittmann, S; Born, C; Bernhard, B; Severus, WE; Grunze, H;
Expert Opin Drug Saf. 2005; 4(5):849-868
Übersichtsarbeiten

Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design.
Grunze, H; Langosch, J; Born, C; Schaub, G; Walden, J;
J Clin Psychiatry. 2003; 64(7):781-784
Originalarbeiten (Zeitschrift)

Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol.
Grunze, H; Marcuse, A; Schärer, LO; Born, C; Walden, J;
Neuropsychobiology. 2002; 46 Suppl 1:31-35
Originalarbeiten (Zeitschrift)

Intralymphatic interleukin-2 in combination with zidovudine for the therapy of patients with AIDS.
Harrer, T; Schwab, J; Struff, WG; Schmitt, M; Ficker, JH; Rodl, W; Parsch, H; Kalden, JR; Gramatzki, M
Infection. 1998; 26(6):368-374
Originalarbeiten (Zeitschrift)

Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial.
Krajnik, G; Wein, W; Greil, R; Marhold, F; Mohn-Staudner, A; Kummer, F; Malayeri, R; Zöchbauer-Müller, S; Huber, H; Pirker, R;
Eur J Cancer. 1998; 34(12): 1977-1980.
Originalarbeiten (Zeitschrift)

Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.
Thaler, J; Hilbe, W; Apfelbeck, U; Linkesch, W; Sill, H; Seewann, H; Pont, J; Bernhart, M; Stöger, M; Niessner, H; Abbrederis, K; Geissler, D; Hausmaninger, H; Lin, W; Ludwig, H; Lang, A; Duba, C; Fluckinger, T; Greil, R; Grünewald, K; Konwalinka, G; Niederwieser, D; Fridrik, M;
Leuk Res. 1997; 21(1):75-80
Originalarbeiten (Zeitschrift)

A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
Hebenstreit, GF; Laux, G; Schubert, H; Beckmann, H; Amman, J; Bunse, J; Eikmeier, G; Geretsegger, C; Kanitz, RD; Kanzow, WT;
Pharmacopsychiatry. 1991; 24(5): 153-158.
Originalarbeiten (Zeitschrift)

Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria.
Hebenstreit, GF; Loidl, M; Baumhackl, U; Gallhofer, B; Geretsegger, C; Radmayr, E; Saletu, M; Schöny, W; Stabl, M;
J Neural Transm Suppl. 1990; 32:177-184
Originalarbeiten (Zeitschrift)